AI-generated summary
In this single-arm, open-label pilot study, the authors examined transcranial photobiomodulation using 810 nm near-infrared light in 16 male firefighters over 8 weeks. The authors report pre- to post-treatment improvements in mood, post-traumatic stress symptoms, pain interference and cognitive measures, with no significant side effects. The study had no control group and was described as a small proof-of-concept study.
- Participants
- 16
- Who or what was studied
- Male firefighters (first responders)
- Wavelengths
- 810 nm
- Limits stated in the abstract
- Small sample, open-label single-arm design with no control group, and described as a proof-of-concept study requiring additional research.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
First responders are often exposed to many physically and mentally stressful events throughout their careers, and common complaints include poor sleep quality, chronic pain, post-traumatic stress symptoms, mood dysregulation, and cognitive impairments.
Objective
We performed an open protocol, active treatment-only study with a small sample of male firefighters (n = 16) to examine the effects of transcranial photobiomodulation (PBM) on self-reported symptom measures and objective measures of cognitive function.
Methods/Materials And Methods
The treatment consisted of 810 nm near-infrared light to the head using four transcranial LEDs and one intranasal LED. Treatment duration was 20 min per session, 3-4 sessions per week for 8 weeks.
Results
We found significant pre-/post-treatment improvements with moderate-to-large effect sizes in mood and post-traumatic stress symptoms, pain interference, and readiness for social reintegration, and across all measures of fluid cognition.
Conclusions
This proof-of-concept study also demonstrated no significant side effects, good compliance, and feasibility of use in a first responder population. Though additional research is required, PBM may present a relatively cost-effective, well-tolerated, low-risk, and easy-to-use treatment to enhance both specific symptoms and general wellness.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Transcranial photobiomodulation, Wellness, Pilot study, Light-emitting diode, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.